IPSEN (EPA:IPN) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
IPSEN

BRIEF

published on 09/23/2024 at 11:01, 1 month 27 days ago

Parvus Asset Management crosses threshold in IPSEN SA

Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
BRIEF

published on 09/16/2024 at 14:50, 2 months 4 days ago

Promising results for Cabometyx in advanced neuroendocrine tumors

Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
PRESS RELEASE

published on 09/16/2024 at 14:45, 2 months 4 days ago

Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM

Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
BRIEF

published on 09/15/2024 at 14:50, 2 months 5 days ago

New analysis of the CONTACT-02 trial by Ipsen

Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx
PRESS RELEASE

published on 08/13/2024 at 18:00, 3 months 7 days ago

IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
BRIEF

published on 05/28/2024 at 07:05, 5 months 24 days ago

Ipsen Announces Share Repurchase Program Details

Annual General Meeting Share Repurchase Corporate Governance Investment Stock Buyback
BRIEF

published on 05/28/2024 at 07:05, 5 months 24 days ago

Ipsen Proposes Share Repurchase Program at Annual General Meeting

Annual General Meeting French Commercial Code Share Repurchase Stock Buyback Ipsen
PRESS RELEASE

published on 05/28/2024 at 07:00, 5 months 24 days ago

Description of the regulatory framework of the share repurchase program proposed by the Board of Directors to be approved at Ipsen S.A.’s Annual General Meeting on 28 May 2024
Ipsen S.A. presents the regulatory framework of the share repurchase program proposed at the Annual General Meeting on 28 May 2024, covering objectives, characteristics, maximum repurchase amount, price, and duration

Annual General Meeting Share Repurchase Program Regulatory Framework Ipsen S.A. Maximum Repurchase Price
BRIEF

published on 05/07/2024 at 15:00, 6 months 13 days ago

Ipsen S.A. Announces Details for 2024 Annual General Meeting

Board Of Directors Annual General Meeting Regulatory Compliance Dividend Ipsen S.A.
PRESS RELEASE

published on 05/07/2024 at 14:55, 6 months 13 days ago

Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
Ipsen S.A. to hold Combined Shareholders’ Meeting on 28 May 2024, revealing resolutions including dividend payment & appointment renewals. Documents available for shareholder review

Dividend Payment Ipsen S.A. Combined Shareholders’ Meeting Appointment Renewals Shareholder Review

Accesswire

Published on 11/21/2024 at 10:03, 31 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 34 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 34 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 59 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 9 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 29 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 34 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 34 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 33 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 36 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 14 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 49 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE